Minister of Economic Affairs Olli Rehn: Finnish government actions to boost health industry growth
Symposium: Brain diseases – why to invest in research in Finland Helsinki 14 October 2016
Ladies and Gentlemen,
Thank you for inviting me to share our government´s on-going actions and plans in boosting the health industry growth. I am honored to address a symposium with such an important cause and diverse group of organizations and talented individuals.
I am very pleased to be today here in Meilahti for various reasons. As a former professor myself, I am always very enthusiastic to visit a university. As the Minister of Economic Affairs, I am very excited of the progress and results of the public-private collaboration and the plans going forward in Helsinki Health capital and Academic Medical Center, which I will visit later today.
Developments here are an example of the major progress during the past year on how the collaboration between universities, hospitals and industry has widened and entered into a new level. The same development is also going on in Oulu, Kuopio, Tampere and Turku. Going forward, I believe that further success can be achieved by intensifying the collaboration on national level as well.
Finland has invested in health-related science, research and education, as well as to research infrastructures and extensive public healthcare system for decades. Now these investments are starting to bear fruit not only in healthcare but also as a source for innovation, business opportunities, jobs and economic growth.
Helping to resolve the health challenges by providing new solutions for health and wellbeing has become one of Finland's strengths. Finland’s health sector and the sector’s international links have grown at a faster pace than many other sectors in recent years. Today, Finland is a home of key centers of excellence for many globally operating corporations and has globally recognized research and technology spearheads in the health sector.
Our common effort and investments are now delivering tangible results.
Health technology, life sciences, digital health and wellbeing solutions as well as research related services are estimated to generate at the moment some 5 billion Euros as economic output annually (2,5% of Finland´s GDP). According to the industry association, health technology accounts for about half of Finnish high-tech exports, having reached a new record level of €1.92 billion in 2015.
The growth of both domestic and foreign direct investments and number of new research collaboration agreements signals that the opportunities offered by our operating environment and innovation ecosystem are also recognized elsewhere.
In spite of the breakthroughs in research, growth of exports and number of new investment plans, we still have room to improve to benefit from the opportunities available.
Digital health, personalized medicine and healthcare, as well as scientific research in areas, such as cancer and brain diseases are among the areas where Finnish knowhow is world-class. Interestingly, these are corresponding to areas where need for new innovations and solutions is in high demand.
Thinking big and global in this regard cannot be emphasized too much – only by having the right level of ambition and being one of the best you can attract investments, funding, talent and market share.
In order to be successful in benefitting from the opportunities, we need cooperation between companies of different sizes from different fields – both domestic and foreign – and research institutions, universities, hospitals, biobanks and investors.
Enhancing this type of multidisciplinary public-private cooperation is a key objective of Finland’s Health Sector Growth Strategy. The strategy was created and continues to be implemented jointly by ministries, key funding agencies, industry, universities and university hospitals. The recent growth in the sector and the new innovations and companies entering the market are an indication that, by working and innovating together, we are on right track.
Boosting health sector growth is one of the key priorities in our overall growth policy. We are building on our strengths, thus Digital health and personalized medicine are at the core of the growth strategy.
Us Finns have high trust in science. “In science we trust.” Being able to rely on ethically sound legislation and research practices is not only important for our citizens, but a trustworthy environment is also a key enabler for research community and the companies doing research in Finland.
As we are drafting and implementing new legislation we continue to take into account citizens’ fundamental rights, data protection and privacy when building research- and innovation-friendly operating environment. We already have good experience of balancing the different needs in the biobank legislation, and these same principles are high on our agenda when now drafting the law on utilization of health data in research and innovation and enabling new digital services in healthcare.
By the way, let me mention in this context that later today I will give my consent for Helsinki Biobank to contribute to science, innovation and development of personalised healthcare.
I will next go through some of the on-going actions, investments and plans we are implementing: As pharmaceutical industry and research institutes are looking for more effective ways to do research utilizing big data and advanced analytics, the combination of our world-class biobanks, relatively isolated gene pool, extensive healthcare registries and the innovation friendly biobank regulation creates a very competitive environment internationally. Government recently announced a package of investments, totaling 17 million euros to make these unique assets of Finland even stronger.
National Genome Centre and national Comprehensive Cancer Center Finland will be established in Finland. As part of this investment package we are also taking actions to enhance collaboration of our biobanks. At a time of tight public finances, this level of funding is a strong statement and reflects our commitment
Without doubt health-related science, research and education as well as research infrastructures and healthcare has been one of the most heavily invested areas of our society for decades. However, the high-quality basic research has resulted in fewer innovations and commercial applications than we would have expected and hoped for.
In the funding for health sector research provided by Tekes and the Academy of Finland and in the development of mutually complementary funding instruments, key objectives now include increasing the impact of research and enabling the utilization of research results. Challenge Finland, Research Benefit and Innovation Scout are examples of the programs going on. Collaboration between Academy of Finland and Tekes to support commercialization of the most potential Academy funded health research is also on-going.
Another essential objective for improving R&D impact is to boost the profiling and division of work between different players. In the health sector, nationally networked and strong hubs representing specific research fields could help to reach results and attract talent, as well as knowledge intensive companies and funding on the levels that no player would be able to achieve alone. Academy of Finland provides funding for this.
In the reform of Finland’s social welfare and healthcare sectors, many processes and structures within healthcare will be renewed. The reform cannot be realized without utilizing the opportunities that technology, digitalisation and new treatments offer. At the same time we have an opportunity to look at ways to strengthen public-private collaboration in research and innovation.
New test environments and reference sites will play a crucial role in the evolution of the sector. The Government has set a goal by which 5% of public procurement will be innovative procurement.
According to Academy of Finland and the Finnish Research Council, the quality and level of the neuroscientific research in Finland has reached the international cutting edge.. A key opportunity lies now in further strengthening the co-operation between the various universities, university hospitals and research institutes. Moreover, opportunities exist in intensifying collaboration within the Finnish multidisciplinary neuroscientific community, as well as increasing collaboration with the industry and healthcare.
Major growth potential exists in this field. Success in the global competition is calling for joining forces and an intensification of “intra-Finnish” domestic collaboration, i.e. that our national actors join forces in order to create centers of excellence and infrastructures with truly international significance and potential. This is achievable when key actors recognize their common interest and work together to achieve success.
The Government is committed to further developing Finland as a competitive environment for health-sector research, innovation and business. We do not pick the winners, and it is up to companies, universities and university hospitals how the possibilities are utilized. Finland’s future success in this demanding but fruitful market will depend on the added value and the effectiveness of all of our actions. Best of success in that endeavor!